The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 05, 2025

Filed:

Aug. 29, 2022
Applicants:

Abion Inc., Seoul, KR;

Seoul National University R&db Foundation, Seoul, KR;

Inventors:

Young Kee Shin, Seoul, KR;

Tae Eun Kim, Anyang-si, KR;

Sung Youl Hong, Incheon, KR;

Jun Young Choi, Gwangmyeong-si, KR;

Na Young Kim, Anyang-si, KR;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/21 (2006.01); A61K 31/713 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/215 (2013.01); A61K 31/713 (2013.01); A61K 39/00 (2013.01); A61P 35/00 (2018.01);
Abstract

The present invention relates to a composition for treating or sensitizing interferon beta resistant cancer disease comprising cFLIP siRNA, and, more specifically, to a pharmaceutical composition for treating interferon beta resistant cancer disease, comprising, as an active ingredient: (a) an siRNA complementarily binding to mRNA of a cFLIP gene; and (b) a human interferon beta variant which comprises glycine-asparagine-isoleucine-threonine-valine sequence (GNITV) at C-terminus in a human natural interferon beta amino acid sequence shown in SEQ ID NO: 1, or has replaced the 27arginine amino acid with threonine or serine.


Find Patent Forward Citations

Loading…